Form 4: Humana Chief Information Officer Reports Stock Transactions
SEC Form 4 Filing
Humana's Chief Information Officer, Samir Deshpande, reported the vesting of restricted stock units and the subsequent sale of shares to cover tax liabilities.
Summary
- Samir Deshpande, Chief Information Officer of Humana Inc., reported several transactions involving Humana common stock on December 15, 2024.
- These transactions include the vesting of restricted stock units and the subsequent disposal of shares to cover tax obligations.
- Specifically, 221 shares were disposed of at a price of $271.675 per share to cover taxes related to the vesting of 353 restricted stock units.
- Additionally, 160 shares were disposed of at $271.675 per share for taxes related to 335 restricted stock units vesting.
- A further 152 shares were disposed of at $271.675 per share for taxes related to the vesting of restricted stock units.
- The transactions also include the acquisition of 353 and 335 restricted stock units at $0 price.
- Following these transactions, Mr. Deshpande beneficially owns 14,015 shares of Humana common stock and various stock options.
Sentiment
Score: 7
Explanation: The document reflects routine transactions related to executive compensation. While the sale of shares might be seen as slightly negative, it is a common practice for tax purposes and does not indicate any significant negative sentiment.
Positives
- The vesting of restricted stock units indicates that performance milestones were likely met.
- The reporting of these transactions is in compliance with SEC regulations.
Negatives
- The sale of shares to cover tax liabilities resulted in a reduction of Mr. Deshpande's direct shareholdings.
Risks
- The sale of shares by an executive could be interpreted negatively by some investors, although it is a common practice for tax purposes.
- Fluctuations in the stock price could impact the value of the remaining shares and options held by Mr. Deshpande.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the ownership changes of company insiders.
Comparison to Industry Standards
- The reporting of stock transactions by executives is a standard practice across all publicly listed companies in the US.
- The vesting schedules and option grants are typical for executive compensation packages in the healthcare industry.
- Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also have similar reporting requirements for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation practices.
- The sale of shares by an executive could be interpreted negatively by some investors, although it is a common practice for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/24/2020 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/21 to 2/24/23. |
| 02/22/2021 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/22/22 to 2/22/24. |
| 02/21/2022 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/23 to 2/21/25. Restricted stock units granted, 33% vesting on 12/15/22, 12/15/23, and 12/15/24. |
| 02/24/2023 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/24/24 to 2/24/26. Restricted stock units granted, 33% vesting on 12/15/23, 12/15/24, and 12/15/25. |
| 02/21/2024 | Incentive and Non-Qualified stock options granted to reporting person, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 12/15/2024 | Date of reported stock transactions, including vesting of restricted stock units and sale of shares for tax liabilities. |
| 12/17/2024 | Date of signature on the SEC Form 4. |
Keywords
Humana, Stock Transactions, Restricted Stock Units, SEC Form 4, Insider Trading, Samir Deshpande, Chief Information Officer, Stock Options, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.